A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines
Related Experiment Video
Updated: Nov 21, 2025

Genome Editing in the Yellow Fever Mosquito Aedes aegypti using CRISPR-Cas9
Published on: March 21, 2025
Kathryn Rozen-Gagnon1, Soon Yi2, Eliana Jacobson2
1Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, 10065, USA. krozen@rockefeller.edu.
Abstract:
Aedes (Ae.) aegypti and Ae. albopictus mosquitoes transmit arthropod-borne diseases around the globe, causing ~ 700,000 deaths each year. Genetic mutants are valuable tools to interrogate both fundamental vector biology and mosquito host factors important for viral infection. However, very few genetic mutants have been described in mosquitoes in comparison to model organisms. The relative ease of applying CRISPR/Cas9-based gene editing has transformed genome engineering and has rapidly increased the number of available gene mutants in mosquitoes. Yet, in vivo studies may not be practical for screening large sets of mutants or possible for laboratories that lack insectaries. Thus, it would be useful to adapt CRISPR/Cas9 systems to common mosquito cell lines. In this study, we generated and characterized a mosquito optimized, plasmid-based CRISPR/Cas9 system for use in U4.4 (Ae. albopictus) and Aag2 (Ae. aegypti) cell lines. We demonstrated highly efficient editing of the AGO1 locus and isolated U4.4 and Aag2 cell lines with reduced AGO1 expression. Further, we used homology-directed repair to establish knock-in Aag2 cell lines with a 3xFLAG-tag at the N-terminus of endogenous AGO1. These experimentally verified plasmids are versatile, cost-effective, and efficiently edit immune competent mosquito cell lines that are widely used in arbovirus studies.
Insights
Researchers developed a CRISPR/Cas9 gene editing system for mosquito cell lines. This tool efficiently creates genetic mutants in Aedes aegypti and Aedes albopictus cell lines, aiding arbovirus research.
Area of Science:
- Vector Biology
- Genetics
- Molecular Biology
Background:
- Arthropod-borne diseases transmitted by Aedes mosquitoes cause significant global mortality.
- Genetic mutants are crucial for studying vector biology and viral infection mechanisms.
- Limited genetic mutants exist for mosquitoes compared to model organisms, hindering research.
Purpose of the Study:
- To develop and characterize a mosquito-optimized, plasmid-based CRISPR/Cas9 system for use in Aedes aegypti and Aedes albopictus cell lines.
- To establish efficient gene editing methods in mosquito cell lines for creating genetic mutants.
- To facilitate arbovirus research by providing accessible tools for mosquito cell line engineering.
Main Methods:
- Generation and characterization of a plasmid-based CRISPR/Cas9 system tailored for mosquito cells.
- Application of the system in U4.4 (Ae. albopictus) and Aag2 (Ae. aegypti) cell lines.
- Utilizing homology-directed repair for knock-in applications, specifically tagging AGO1.
Main Results:
- Demonstrated highly efficient editing of the AGO1 locus in both cell lines.
- Successfully isolated U4.4 and Aag2 cell lines with reduced AGO1 expression.
- Established Aag2 cell lines with a 3xFLAG-tag at the N-terminus of endogenous AGO1 via homology-directed repair.
Conclusions:
- The developed CRISPR/Cas9 system is versatile, cost-effective, and efficient for editing key mosquito cell lines.
- This system enables the creation of genetic mutants in immune-competent mosquito cell lines widely used in arbovirus studies.
- The tool facilitates fundamental research into mosquito biology and host-pathogen interactions relevant to disease transmission.
More Related Videos
07:45Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9
Published on: September 10, 2020
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR